SEL ICB Lambeth Community Denosumab Service

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-068c80-2026-07-08T09:13:17+01:00",
    "date": "2026-07-08T09:13:17+01:00",
    "ocid": "ocds-h6vhtk-068c80",
    "description": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by Tuesday 12th May 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Written representations should be sent to: hub.psrrepresentation@nhs.net Award Decision makers: Andrew Eyres- Corporate Director, Integrated Health and Adult Social Care There was no conflict of interest identified in the decision-making process. Evaluation Criteria and Weighting Scoring from 0-4, with percentage allocation based on the importance of the criteria in the service requirement. Key criteria: Quality and Innovation: 20% Value for Money: 25% Integration, Collaboration and Service Sustainability: 20% Improving Access, Reducing Health Inequalities and Facilitating Choice: 25% Social Value: 10% The criteria were applied with their respective weightings as specified, with scoring against a number of sub-categories for each criterion. An assessment against current and future performance for these individual sub-categories was undertaken, resulting in a combined overall score out of 100%. The publication of this notice marks the start of the standstill period, commencing on Wednesday 30th April 2026 ending at 23:59 on Tuesday 12 May 2026. Representations by providers must be submitted by 23:59 on Tuesday 12 May 2026 to: hub.psrrepresentation@nhs.net and must be made to the decision makers within this period. The contract may be formally awarded on Wednesday 13 May 2026, provided no representations are received, or once any representations have been addressed. This contract has not yet formally been awarded; this notice serves as an intention to award under the Provider Selection Regime (PSR). No conflicts of interest were identified in the decision-making process. Decision Makers and Dates of Decision The decision to proceed with the intention to award was made by: Andrew Eyres- Corporate Director, Integrated Health and Adult Social Care Lambeth Together Planning and Finance Group - 23 March 2026 Lambeth Together Senior Management Team - 31 March 2026 Rationale for Selection of Current Provider The current provider has demonstrated sustained high-quality performance and value for money, including: Maintaining 100% performance across key service standards, including: -Provision of service to all appropriately referred patients -Contacting patients within 72 hours of referral from secondary care -Issuing patient reminder cards and information leaflets -Providing consistent feedback from service users and referring acute trusts -Reporting 0% near misses or incidents from both the provider and acute trust -Effective financial management, remaining within the agreed budget -Delivery in line with NICE TA204 (Denosumab for the prevention of osteoporotic fractures in postmenopausal women) -Alignment with the South East London Osteoporosis Pathway and the South East London Shared Care Agreement for Denosumab 60mg/ml -Supporting care closer to home and improved patient experience through community-based administration of treatment -Sustained achievement of >=95% across key performance indicators, including: -Timely patient contact within 72 hours -Provision of patient information materials -Service user and referrer feedback mechanisms -Incident reporting compliance -Annual patient satisfaction feedback demonstrating good service experience",
    "initiationType": "tender",
    "tender": {
        "id": "ocds-h6vhtk-068c80",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "SEL ICB Lambeth Community Denosumab Service",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "85141000",
            "description": "Services provided by medical personnel"
        },
        "mainProcurementCategory": "services",
        "description": "Provision of a community-based shared care service for the administration and monitoring of denosumab 60mg/ml for osteoporosis. The service will support patients in Lambeth (or registered with a Lambeth GP) who have been identified by secondary care as clinically appropriate for treatment in the community. The Provider will deliver blood monitoring, prescribing support, and timely administration of injections in accordance with the South East London Shared Care Agreement, while clinical responsibility remains with secondary care.",
        "lots": [
            {
                "id": "1",
                "description": "This notice relates to the Lambeth Community Denosumab Service and is an intention to award a contract to the existing provider via Direct Award Process C. The service provides a community-based shared care pathway for patients prescribed denosumab 60mg/ml for the treatment of osteoporosis. Patients remain under the clinical responsibility of secondary care within South East London, in accordance with the South East London Shared Care Agreement for Denosumab. Secondary care will identify and refer a cohort of clinically appropriate patients for management in the community setting. The Provider will be responsible for delivering the community service, including required blood monitoring, prescribing support, and administration of denosumab injections at clinically appropriate intervals. The service is available to patients referred by secondary care who are registered with a GP in Lambeth or are Lambeth residents and who meet the eligibility criteria set out in the contract and Shared Care Agreement. The estimated contract value is PS49,140 per annum. The contract duration is 6 months from 01/06/2026 to 30/11/2026, with an option to extend for a further 6 months at the discretion of the Authority, up to 31/05/2027. This is a direct award with no competition under the Provider Selection Regime (PSR) - Direct Award Process C. As such, no award criteria were applied. The contracting authority has determined that the existing provider will be awarded the contract on the basis that: The current provider is delivering the service to a satisfactory standard. There are no proposed changes to the existing contract terms. Continuity of care is essential for this patient cohort The provider continues to meet all relevant clinical, quality, and service requirements. The decision is made in accordance with PSR requirements for Direct Award Process C. Additional information: Procurement Route This contract is intended to be awarded under the Provider Selection Regime (PSR) - Direct Award Process C. Rationale for Direct Award The current provider is delivering the service to a satisfactory standard, and there are no proposed changes to the existing contract terms. Continuity of care is essential for this patient cohort. The provider continues to meet all relevant clinical, quality, and service requirements. Decision The Contracting Authority intends to award the contract to the existing provider in accordance with PSR Direct Award Process C.",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "Award Criteria: Cost & Quality criteria Cost & Quality criterion: the existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard Weighting: 100%",
                            "type": "cost",
                            "description": "100%"
                        }
                    ]
                },
                "hasOptions": true,
                "options": {
                    "description": "The Contracting Authority may, at its discretion, may extend the contract for a further period of up to 6 months."
                },
                "status": "cancelled"
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "85141000",
                        "description": "Services provided by medical personnel"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKI45"
                    }
                ],
                "deliveryLocation": {
                    "description": "Community-based healthcare settings within Lambeth; patients registered with Lambeth GP practices or resident in Lambeth."
                },
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
        "coveredBy": [
            "GPA"
        ],
        "reviewDetails": "The publication of this notice marks the start of the standstill period, commencing on Wednesday 30th April 2026 ending at 23:59 on Tuesday 12 May 2026. Representations by providers must be submitted by 23:59 on Tuesday 12 May 2026 to: hub.psrrepresentation@nhs.net and must be made to the decision makers within this period. The contract may be formally awarded on Wednesday 13 May 2026, provided no representations are received, or once any representations have been addressed..",
        "procurementMethodRationaleClassifications": [
            {
                "id": "D_PROC_OPEN",
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
                "description": "No tenders or no suitable tenders/requests to participate in response to open procedure"
            }
        ],
        "procurementMethodRationale": "Justification: Award of a contract without prior publication of a call for competition in the cases listed below Reason: The procurement falls outside the scope of application of the regulations Explanation: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by Tuesday 12th May 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.",
        "amendments": [
            {
                "id": "1",
                "unstructuredChanges": [
                    {
                        "oldValue": {
                            "text": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by Tuesday 12th May 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Written representations should be sent to: hub.psrrepresentation@nhs.net Award Decision makers: Andrew Eyres- Corporate Director, Integrated Health and Adult Social Care There was no conflict of interest identified in the decision-making process. Evaluation Criteria and Weighting Scoring from 0-4, with percentage allocation based on the importance of the criteria in the service requirement. Key criteria: Quality and Innovation: 20% Value for Money: 25% Integration, Collaboration and Service Sustainability: 20% Improving Access, Reducing Health Inequalities and Facilitating Choice: 25% Social Value: 10% The criteria were applied with their respective weightings as specified, with scoring against a number of sub-categories for each criterion. An assessment against current and future performance for these individual sub-categories was undertaken, resulting in a combined overall score out of 100%. The publication of this notice marks the start of the standstill period, commencing on Wednesday 30th April 2026 ending at 23:59 on Tuesday 12 May 2026. Representations by providers must be submitted by 23:59 on Tuesday 12 May 2026 to: hub.psrrepresentation@nhs.net and must be made to the decision makers within this period. The contract may be formally awarded on Wednesday 13 May 2026, provided no representations are received, or once any representations have been addressed. This contract has not yet formally been awarded; this notice serves as an intention to award under the Provider Selection Regime (PSR). No conflicts of interest were identified in the decision-making process. Decision Makers and Dates of Decision The decision to proceed with the intention to award was made by: Andrew Eyres- Corporate Director, Integrated Health and Adult Social Care Lambeth Together Planning and Finance Group - 23 March 2026 Lambeth Together Senior Management Team - 31 March 2026 Rationale for Selection of Current Provider The current provider has demonstrated sustained high-quality performance and value for money, including: Maintaining 100% performance across key service standards, including: -Provision of service to all appropriately referred patients -Contacting patients within 72 hours of referral from secondary care -Issuing patient reminder cards and information leaflets -Providing consistent feedback from service users and referring acute trusts -Reporting 0% near misses or incidents from both the provider and acute trust -Effective financial management, remaining within the agreed budget -Delivery in line with NICE TA204 (Denosumab for the prevention of osteoporotic fractures in postmenopausal women) -Alignment with the South East London Osteoporosis Pathway and the South East London Shared Care Agreement for Denosumab 60mg/ml -Supporting care closer to home and improved patient experience through community-based administration of treatment -Sustained achievement of >=95% across key performance indicators, including: -Timely patient contact within 72 hours -Provision of patient information materials -Service user and referrer feedback mechanisms -Incident reporting compliance -Annual patient satisfaction feedback demonstrating good service experience"
                        },
                        "newValue": {
                            "text": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by Tuesday 12th May 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Written representations should be sent to: hub.psrrepresentation@nhs.net Award Decision makers: Andrew Eyres- Corporate Director, Integrated Health and Adult Social Care There was no conflict of interest identified in the decision-making process. Evaluation Criteria and Weighting Scoring from 0-4, with percentage allocation based on the importance of the criteria in the service requirement. Key criteria: Quality and Innovation: 20% Value for Money: 25% Integration, Collaboration and Service Sustainability: 20% Improving Access, Reducing Health Inequalities and Facilitating Choice: 25% Social Value: 10% The criteria were applied with their respective weightings as specified, with scoring against a number of sub-categories for each criterion. An assessment against current and future performance for these individual sub-categories was undertaken, resulting in a combined overall score out of 100%. The publication of this notice marks the start of the standstill period, commencing on Thursday 30th April 2026 ending at 23:59 on Tuesday 12 May 2026. Representations by providers must be submitted by 23:59 on Tuesday 12 May 2026 to: hub.psrrepresentation@nhs.net and must be made to the decision makers within this period. The contract may be formally awarded on Wednesday 13 May 2026, provided no representations are received, or once any representations have been addressed. This contract has not yet formally been awarded; this notice serves as an intention to award under the Provider Selection Regime (PSR). No conflicts of interest were identified in the decision-making process. Decision Makers and Dates of Decision The decision to proceed with the intention to award was made by: Andrew Eyres- Corporate Director, Integrated Health and Adult Social Care Lambeth Together Planning and Finance Group - 23 March 2026 Lambeth Together Senior Management Team - 31 March 2026 Rationale for Selection of Current Provider The current provider has demonstrated sustained high-quality performance and value for money, including: Maintaining 100% performance across key service standards, including: -Provision of service to all appropriately referred patients -Contacting patients within 72 hours of referral from secondary care -Issuing patient reminder cards and information leaflets -Providing consistent feedback from service users and referring acute trusts -Reporting 0% near misses or incidents from both the provider and acute trust -Effective financial management, remaining within the agreed budget -Delivery in line with NICE TA204 (Denosumab for the prevention of osteoporotic fractures in postmenopausal women) -Alignment with the South East London Osteoporosis Pathway and the South East London Shared Care Agreement for Denosumab 60mg/ml -Supporting care closer to home and improved patient experience through community-based administration of treatment -Sustained achievement of >=95% across key performance indicators, including: -Timely patient contact within 72 hours -Provision of patient information materials -Service user and referrer feedback mechanisms -Incident reporting compliance -Annual patient satisfaction feedback demonstrating good service experience"
                        },
                        "where": {
                            "section": "VI.3",
                            "label": "VI.3 Additional information"
                        }
                    },
                    {
                        "oldValue": {
                            "text": "The publication of this notice marks the start of the standstill period, commencing on Wednesday 30th April 2026 ending at 23:59 on Tuesday 12 May 2026. Representations by providers must be submitted by 23:59 on Tuesday 12 May 2026 to: hub.psrrepresentation@nhs.net and must be made to the decision makers within this period. The contract may be formally awarded on Wednesday 13 May 2026, provided no representations are received, or once any representations have been addressed."
                        },
                        "newValue": {
                            "text": "The publication of this notice marks the start of the standstill period, commencing on Thursday 30th April 2026 ending at 23:59 on Tuesday 12 May 2026. Representations by providers must be submitted by 23:59 on Tuesday 12 May 2026 to: hub.psrrepresentation@nhs.net and must be made to the decision makers within this period. The contract may be formally awarded on Wednesday 13 May 2026, provided no representations are received, or once any representations have been addressed."
                        },
                        "where": {
                            "section": "VI.4.3.",
                            "label": "Precise information on deadline(s) for review procedures"
                        }
                    }
                ]
            },
            {
                "id": "2",
                "unstructuredChanges": [
                    {
                        "oldValue": {
                            "text": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by Tuesday 12th May 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Written representations should be sent to: hub.psrrepresentation@nhs.net Award Decision makers: Andrew Eyres- Corporate Director, Integrated Health and Adult Social Care There was no conflict of interest identified in the decision-making process. Evaluation Criteria and Weighting Scoring from 0-4, with percentage allocation based on the importance of the criteria in the service requirement. Key criteria: Quality and Innovation: 20% Value for Money: 25% Integration, Collaboration and Service Sustainability: 20% Improving Access, Reducing Health Inequalities and Facilitating Choice: 25% Social Value: 10% The criteria were applied with their respective weightings as specified, with scoring against a number of sub-categories for each criterion. An assessment against current and future performance for these individual sub-categories was undertaken, resulting in a combined overall score out of 100%. The publication of this notice marks the start of the standstill period, commencing on Wednesday 30th April 2026 ending at 23:59 on Tuesday 12 May 2026. Representations by providers must be submitted by 23:59 on Tuesday 12 May 2026 to: hub.psrrepresentation@nhs.net and must be made to the decision makers within this period. The contract may be formally awarded on Wednesday 13 May 2026, provided no representations are received, or once any representations have been addressed. This contract has not yet formally been awarded; this notice serves as an intention to award under the Provider Selection Regime (PSR). No conflicts of interest were identified in the decision-making process. Decision Makers and Dates of Decision The decision to proceed with the intention to award was made by: Andrew Eyres- Corporate Director, Integrated Health and Adult Social Care Lambeth Together Planning and Finance Group - 23 March 2026 Lambeth Together Senior Management Team - 31 March 2026 Rationale for Selection of Current Provider The current provider has demonstrated sustained high-quality performance and value for money, including: Maintaining 100% performance across key service standards, including: -Provision of service to all appropriately referred patients -Contacting patients within 72 hours of referral from secondary care -Issuing patient reminder cards and information leaflets -Providing consistent feedback from service users and referring acute trusts -Reporting 0% near misses or incidents from both the provider and acute trust -Effective financial management, remaining within the agreed budget -Delivery in line with NICE TA204 (Denosumab for the prevention of osteoporotic fractures in postmenopausal women) -Alignment with the South East London Osteoporosis Pathway and the South East London Shared Care Agreement for Denosumab 60mg/ml -Supporting care closer to home and improved patient experience through community-based administration of treatment -Sustained achievement of >=95% across key performance indicators, including: -Timely patient contact within 72 hours -Provision of patient information materials -Service user and referrer feedback mechanisms -Incident reporting compliance -Annual patient satisfaction feedback demonstrating good service experience"
                        },
                        "newValue": {
                            "text": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by Tuesday 12th May 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Written representations should be sent to: hub.psrrepresentation@nhs.net Award Decision makers: Andrew Eyres- Corporate Director, Integrated Health and Adult Social Care There was no conflict of interest identified in the decision-making process. Evaluation Criteria and Weighting Scoring from 0-4, with percentage allocation based on the importance of the criteria in the service requirement. Key criteria: Quality and Innovation: 20% Value for Money: 25% Integration, Collaboration and Service Sustainability: 20% Improving Access, Reducing Health Inequalities and Facilitating Choice: 25% Social Value: 10% The criteria were applied with their respective weightings as specified, with scoring against a number of sub-categories for each criterion. An assessment against current and future performance for these individual sub-categories was undertaken, resulting in a combined overall score out of 100%. The publication of this notice marks the start of the standstill period, commencing on Thursday 30th April 2026 ending at 23:59 on Tuesday 12 May 2026. Representations by providers must be submitted by 23:59 on Tuesday 12 May 2026 to: hub.psrrepresentation@nhs.net and must be made to the decision makers within this period. The contract may be formally awarded on Wednesday 13 May 2026, provided no representations are received, or once any representations have been addressed. This contract has not yet formally been awarded; this notice serves as an intention to award under the Provider Selection Regime (PSR). No conflicts of interest were identified in the decision-making process. Decision Makers and Dates of Decision The decision to proceed with the intention to award was made by: Andrew Eyres- Corporate Director, Integrated Health and Adult Social Care Lambeth Together Planning and Finance Group - 23 March 2026 Lambeth Together Senior Management Team - 31 March 2026 Rationale for Selection of Current Provider The current provider has demonstrated sustained high-quality performance and value for money, including: Maintaining 100% performance across key service standards, including: -Provision of service to all appropriately referred patients -Contacting patients within 72 hours of referral from secondary care -Issuing patient reminder cards and information leaflets -Providing consistent feedback from service users and referring acute trusts -Reporting 0% near misses or incidents from both the provider and acute trust -Effective financial management, remaining within the agreed budget -Delivery in line with NICE TA204 (Denosumab for the prevention of osteoporotic fractures in postmenopausal women) -Alignment with the South East London Osteoporosis Pathway and the South East London Shared Care Agreement for Denosumab 60mg/ml -Supporting care closer to home and improved patient experience through community-based administration of treatment -Sustained achievement of >=95% across key performance indicators, including: -Timely patient contact within 72 hours -Provision of patient information materials -Service user and referrer feedback mechanisms -Incident reporting compliance -Annual patient satisfaction feedback demonstrating good service experience"
                        },
                        "where": {
                            "section": "VI.3",
                            "label": "Additional information"
                        }
                    },
                    {
                        "oldValue": {
                            "text": "The publication of this notice marks the start of the standstill period, commencing on Wednesday 30th April 2026 ending at 23:59 on Tuesday 12 May 2026. Representations by providers must be submitted by 23:59 on Tuesday 12 May 2026 to: hub.psrrepresentation@nhs.net and must be made to the decision makers within this period. The contract may be formally awarded on Wednesday 13 May 2026, provided no representations are received, or once any representations have been addressed."
                        },
                        "newValue": {
                            "text": "The publication of this notice marks the start of the standstill period, commencing on Thursday 30th April 2026 ending at 23:59 on Tuesday 12 May 2026. Representations by providers must be submitted by 23:59 on Tuesday 12 May 2026 to: hub.psrrepresentation@nhs.net and must be made to the decision makers within this period. The contract may be formally awarded on Wednesday 13 May 2026, provided no representations are received, or once any representations have been addressed."
                        },
                        "where": {
                            "section": "VI.4.3.",
                            "label": "Precise information on deadline(s) for review procedures"
                        }
                    }
                ]
            },
            {
                "id": "3",
                "description": "This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. This contract has now been formally awarded using direct award process C. The contract for Community Based Cardiology Diagnostic Services (Electrocardiogram and Blood Pressure Monitoring) (Contract Reference: 202607SELICB (LAMBETH) XEC) was awarded on 19 May 2026. The services under this contract are intended to be provided from 01 July 2026 to 30 June 2028, with the option to extend for a further 1 + 1 years at the sole discretion of the contracting authority. Should both optional extensions be exercised, the contract term will run until 30 June 2030. The total lifetime value of the contract, excluding VAT, is PS2,311,995. This comprises: Year 1: PS611,374 Years 2-4: PS566,874 per annum The values for Years 3 and 4 are indicative and based on projected activity levels, and are subject to review and agreement prior to extension. During the standstill period, no formal review process was undertaken. The award decision was made by the following individuals: Jenny Sivaganam (Assistant Director, SEL Medicines Optimisation, NHS SEL ICB (Lambeth)) Andrew Eyres (Place Executive Lead for Lambeth and Corporate Director, Integrated Health and Adult Social Care, NHS SEL ICB) Mike Fox (Director of Finance, NHS SEL ICB) No conflicts of interest, either declared or potential, were identified in relation to the individuals involved in the decision-making process. Accordingly, no conflict management actions were required."
            },
            {
                "id": "4",
                "description": "This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. This contract has now been formally awarded using direct award process C. The contract for Community Denosumab Service was awarded on 19 May 2026. The services under this contract are intended to be provided from 01 July 2026 to 30 June 2028, with the option to extend for a further 1 + 1 years at the sole discretion of the contracting authority. Should both optional extensions be exercised, the contract term will run until 30 June 2030. The total lifetime value of the contract, excluding VAT, is PS2,311,995. This comprises: Year 1: PS611,374 Years 2-4: PS566,874 per annum The values for Years 3 and 4 are indicative and based on projected activity levels, and are subject to review and agreement prior to extension. During the standstill period, no formal review process was undertaken. The award decision was made by the following individuals: Jenny Sivaganam (Assistant Director, SEL Medicines Optimisation, NHS SEL ICB (Lambeth)) Andrew Eyres (Place Executive Lead for Lambeth and Corporate Director, Integrated Health and Adult Social Care, NHS SEL ICB) Mike Fox (Director of Finance, NHS SEL ICB) No conflicts of interest, either declared or potential, were identified in relation to the individuals involved in the decision-making process. Accordingly, no conflict management actions were required."
            }
        ]
    },
    "awards": [
        {
            "id": "038464-2026-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-NHS-CQC",
                    "name": "Lambeth Healthcare Ltd"
                }
            ]
        }
    ],
    "parties": [
        {
            "id": "GB-NHS-QKK",
            "name": "NHS South East London Integrated Care Board",
            "identifier": {
                "legalName": "NHS South East London Integrated Care Board",
                "id": "QKK",
                "scheme": "GB-NHS"
            },
            "address": {
                "streetAddress": "160 Tooley Street",
                "locality": "London",
                "region": "UKI45",
                "postalCode": "SE1 2TZ",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "hub.queries@nhs.net"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.selondonics.org/icb/",
                "buyerProfile": "https://www.selondonics.org/icb/",
                "classifications": [
                    {
                        "id": "BODY_PUBLIC",
                        "scheme": "TED_CA_TYPE",
                        "description": "Body governed by public law"
                    },
                    {
                        "id": "07",
                        "scheme": "COFOG",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-NHS-CQC",
            "name": "Lambeth Healthcare Ltd",
            "identifier": {
                "legalName": "Lambeth Healthcare Ltd",
                "id": "CQC",
                "scheme": "GB-NHS"
            },
            "address": {
                "streetAddress": "Akerman Health Centre, Second Floor, 60 Patmos Road",
                "locality": "London",
                "region": "UKI",
                "postalCode": "SW9 6AF",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "hub.queries@nhs.net"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "url": "https://www.selondonics.org/icb/",
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-180912",
            "name": "NHS South East London Integrated Care Board",
            "identifier": {
                "legalName": "NHS South East London Integrated Care Board"
            },
            "address": {
                "streetAddress": "160 Tooley Street,",
                "locality": "London",
                "postalCode": "SE1 2TZ",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "hub.queries@nhs.net"
            },
            "roles": [
                "reviewBody"
            ],
            "details": {
                "url": "https://www.selondonics.org/icb/"
            }
        },
        {
            "id": "GB-FTS-60642",
            "name": "NHS South East London Integrated Care Board",
            "identifier": {
                "legalName": "NHS South East London Integrated Care Board",
                "noIdentifierRationale": "notOnAnyRegister"
            },
            "address": {
                "streetAddress": "160 Tooley Street",
                "locality": "London",
                "region": "UKI45",
                "postalCode": "SE1 2TZ",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "hub.queries@nhs.net"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.selondonics.org/icb/",
                "buyerProfile": "https://www.selondonics.org/icb/"
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-60642",
        "name": "NHS South East London Integrated Care Board"
    },
    "contracts": [
        {
            "id": "038464-2026-1",
            "awardID": "038464-2026-1",
            "status": "active",
            "value": {
                "amount": 49140,
                "currency": "GBP"
            },
            "dateSigned": "2026-04-22T00:00:00+01:00"
        }
    ],
    "bids": {
        "statistics": [
            {
                "id": "1",
                "measure": "bids",
                "relatedLot": "1",
                "value": 1
            }
        ]
    },
    "language": "en"
}